Loading company…
Verinata Health develops non-invasive tests for maternal and fetal health.
Verinata Health develops molecular diagnostic tests for the early identification of fetal chromosomal abnormalities. Founded in 2002, the company is based in San Carlos, US. It is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in